Mode
Text Size
Log in / Sign up

Neurology

1257 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review of post-stroke delirium prediction models finds moderate discriminative ability
Neurology Meta-analysis
Systematic review of post-stroke delirium prediction models finds moderate discriminative ability New Tools Help Spot Confusion After a Stroke
This systematic review and meta-analysis synthesized 12 studies constructing 21 risk prediction models for post-stroke delirium. The combine…
Doctors can now spot dangerous confusion after a stroke more accurately using new prediction tools that look at age and heart health.
Meta-analysis finds robot-assisted training plus acupuncture improves stroke recovery outcomes
Neurology Meta-analysis
Meta-analysis finds robot-assisted training plus acupuncture improves stroke recovery outcomes Robot Therapy Plus Acupuncture Helps Stroke Survivors Walk Better
This systematic review and meta-analysis of 1821 stroke patients found that robot-assisted training plus acupuncture therapy significantly i…
Stroke survivors who get robot therapy plus acupuncture walk farther and regain more leg strength than with either treatment alone.
FDA Approves Nuplazid (pimavanserin) for Parkinson's Disease Psychosis
Neurology FDA Approval
FDA Approves Nuplazid (pimavanserin) for Parkinson's Disease Psychosis FDA approves first drug for hallucinations in Parkinson's disease
The FDA approved Nuplazid (pimavanserin) for hallucinations and delusions associated with Parkinson's disease psychosis. Approval was based …
The FDA approved Nuplazid (pimavanserin) to treat hallucinations and delusions in people with Parkinson's disease psychosis. It is the first…
FDA Approves Nuplazid (pimavanserin) for Parkinson's Disease Psychosis
Neurology FDA Approval
FDA Approves Nuplazid (pimavanserin) for Parkinson's Disease Psychosis FDA approves first drug for hallucinations in Parkinson's disease
FDA approved Nuplazid (pimavanserin) for hallucinations and delusions associated with Parkinson's disease psychosis. In a 6-week trial, Nupl…
The FDA approved Nuplazid (pimavanserin) to treat hallucinations and delusions in people with Parkinson's disease psychosis. It is the first…
Systematic review shows high prevalence of covert cerebrovascular changes in schizophrenia patients compared to controls
Neurology Meta-analysis
Systematic review shows high prevalence of covert cerebrovascular changes in schizophrenia patients compared to controls Brain scans show hidden vessel changes in many people with schizophrenia
This systematic review and meta-analysis evaluated 11,611 patients with schizophrenia and controls from international and Chinese databases.
A large review found hidden signs of blood vessel issues in many people with schizophrenia, though experts urge caution before drawing firm …
Systematic review and meta-analysis shows rTMS reduces post-stroke shoulder pain in stroke survivors
Neurology Meta-analysis
Systematic review and meta-analysis shows rTMS reduces post-stroke shoulder pain in stroke survivors Magnetic pulses ease shoulder pain for stroke survivors
This systematic review and meta-analysis evaluated repetitive transcranial magnetic stimulation (rTMS) for post-stroke shoulder pain in over…
A new analysis of over 500 stroke survivors found magnetic pulses significantly reduced shoulder pain and improved movement compared to stan…
Meta-analysis shows semi-immersive VR improves hand function in post-stroke patients with over 12 hours of therapy
Neurology Meta-analysis
Meta-analysis shows semi-immersive VR improves hand function in post-stroke patients with over 12 hours of therapy Virtual Reality Therapy Improves Hand Function After Stroke
This meta-analysis of randomized controlled trials evaluated virtual reality therapy for patients with hemiplegia after stroke.
A meta-analysis of trials shows virtual reality therapy significantly improves hand function in stroke patients, especially with longer trea…
Laughter yoga reduced fatigue in people with multiple sclerosis in a randomized controlled trial
Neurology RCT
Laughter yoga reduced fatigue in people with multiple sclerosis in a randomized controlled trial Laughter Yoga Cuts Fatigue And Improves Sleep For Multiple Sclerosis Patients
This randomized controlled trial enrolled 42 people with multiple sclerosis.
People with multiple sclerosis who practiced laughter yoga reported less tiredness and better sleep after just twelve sessions.
Glenzocimab fails to improve outcomes in acute ischemic stroke thrombolysis
Neurology RCT
Glenzocimab fails to improve outcomes in acute ischemic stroke thrombolysis New stroke drug shows no benefit for patients treated with clot-busting therapy
This phase 2/3 randomized trial tested glenzocimab versus placebo in 421 patients with acute ischemic stroke treated by thrombolysis.
A major trial found that glenzocimab did not improve long-term disability scores for stroke patients who received standard clot-busting trea…
Meta-analysis finds PLISSIT counseling improves sexual life in women with MS
Neurology Meta-analysis
Meta-analysis finds PLISSIT counseling improves sexual life in women with MS Counseling helps sexual life for women with Multiple Sclerosis
This systematic review and meta-analysis of 232 women with multiple sclerosis found that counseling interventions based on the PLISSIT model…
A new review found counseling based on the PLISSIT model had a high and positive effect on the sexual lives of women with Multiple Sclerosis…
Six weeks of reactive balance training feasibility in community-dwelling adults with chronic stroke
Neurology RCT
Six weeks of reactive balance training feasibility in community-dwelling adults with chronic stroke Six weeks of reactive balance training shows promise for stroke recovery
This pilot feasibility study randomized 28 community-dwelling adults with chronic stroke to six weeks of reactive balance training or tradit…
A pilot study suggests reactive balance training may improve stability in community-dwelling adults with chronic stroke without increasing a…
Exercise training improves cognition and fatigue in older adults with multiple sclerosis
Neurology RCT
Exercise training improves cognition and fatigue in older adults with multiple sclerosis Exercise boosts brain and cuts fatigue in older adults with MS
This Phase-Ib randomized controlled trial in 51 older adults with multiple sclerosis found that 16 weeks of home-based aerobic and resistanc…
A 16-week home exercise program improved thinking speed, executive function, fatigue, and quality of life in older adults with multiple scle…